00919 MODERNHEALTHTEC
- 0.091
- +0.003+3.41%
MODERNHEALTHTEC News
Modern Healthcare Technology Singaporean Arm Buys Vehicle
Modern Healthcare Technology Holdings' (HKG:0919) Singaporean indirect unit purchased a Rolls-Royce Dawn V12 Auto vehicle from F1 Autos for SG$1.2 million, a Monday filing said. The vehicle will be us
Hyundai Health Technology (00919) subsidiary plans to acquire a Rolls-Royce Dawn V12 Auto for 1.22 million Singapore dollars
Zhitong Financial App News, Modern Health Technology (00919) announced that on February 8, 2024, the buyer Splendid Overseas Pte Limited (an indirect wholly-owned subsidiary of the company) and the seller F1 Autos Pte Limited signed a car sales agreement for the purchase. The cost was SGD 1.22 million. According to reports, the object of the purchase was a Rolls-Royce Dawn V12 Auto. The announcement stated that the purpose of purchasing the car was to enhance the group's reputation by improving the shuttle service
MODERNHEALTHTEC: Interim Report 2023/24
Modern Healthcare Technology Swings to Loss in Fiscal H1; Shares Up 4%
Modern Healthcare Technology Holdings (HKG:0919) swung to a loss of HK$28.8 million, or HK$0.0318 per share, in the fiscal first half, from a profit of HK$40.7 million, or HK$0.0449 per share, in the
Modern Health Technology (00919.HK)'s interim earnings decreased 6.3% year over year to HK$210 million
Gelonghui November 28 | Modern Health Technology (00919.HK) announced that for the six months ended September 30, 2023, the Group's revenue decreased by 6.3% compared to the same period last year to HK$210 million. The net loss was approximately HK$285.69 million, while the net profit for the same period last year was HK$40.96 million. The Group will continue to expand its business at the appropriate time to achieve the goal of long-term value growth and bring the highest return to shareholders. For the period under review, the loss per share was HK3.18 cents, while the profit per share for the same period last year was HK4.49 cents. The board of directors has not approved disbursements for the period ending September 30, 2023 6
MODERNHEALTHTEC: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Modern Healthcare Technology to Swing to Loss in Fiscal H1
Modern Healthcare Technology Holdings (HKG:0919) expects to record a loss of HK$20 million in the six months ended Sept. 30, reversing a profit of HK$41 million in the year-ago period, a Wednesday fil
Modern Health Technology (00919.HK) Profit Alert: Expected to lose more than HK$20 million in the medium term
Gelonghui November 22|Modern Health Technology (00919.HK) announced that the company may have recorded a loss of not less than HK$20 million in the six months ending September 30, 2023, while a profit of about HK$41 million was recorded in the same period last year. This result is mainly due to: i) Reduced revenue due to the suspension of our stores from January 7, 2022 to April 20, 2022, in line with Hong Kong's COVID-19 anti-epidemic measures. The suspension of operations drastically reduced the company's deferred revenue from January 7, 2022 to April 20, 2022. What the company has always formulated
Modern Health Technology (00919.HK) will hold a board meeting on November 28 to approve the interim results
Glonghui November 16丨Modern Health Technology (00919.HK) announced that the company will hold a board meeting on November 28, 2023 to approve the publication of the interim results of the company and its subsidiaries for the six months ended September 30, 2023 and to consider the payment of interim dividends (if any).
Modern Health Technology (00919) appoints Lam Tak-leung as an independent non-executive director
Zhitong Financial App News, Modern Health Technology (00919) announced that the board of directors has decided to appoint Mr. Lin Deliang MH, JP as the company's independent non-executive director, effective from October 1, 2023.
MODERNHEALTHTEC: Annual Report 2022/23
Hyundai Health Technology (00919) Releases Annual Results Shareholders' Payable Losses of HK$20.6707 Million Narrowed 70.05% year-on-year
According to the Zhitong Finance App, Hyundai Health Technology (00919) announced results for the year ended March 31, 2023. Group revenue was HK$406 million, up 14.27% year on year; shareholders' losses were HK$206.07 million, down 70.05% year on year; loss of HK2.28 cents per share.
MODERNHEALTHTEC: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023
MODERNHEALTHTEC: PROFIT WARNING - SUPPLEMENTAL ANNOUNCEMENT
Modern Healthcare Technology Warns of Net Loss in FY23
Modern Healthcare Technology Holdings (HKG:0919) warns it will incur a net loss of not less than HK$10 million in the fiscal year ended March 31 compared with a profit of HK$41 million in the six mont
Modern Health Technology (00919) issued a profit alert with an estimated annual loss of not less than HK$10 million
According to the Zhitong Finance App, Hyundai Health Technology (00919) announced that the company's revenue from October 1, 2022 to March 31, 2023 may be significantly lower than the revenue obtained in the six months ending September 30, 2022. As a result, it lost no less than HK$10 million for the year ending March 31, 2023, and made a profit of about HK$41 million for the six months ended September 30, 2022. This is mainly due to compliance with Hong Kong's anti-epidemic measures against COVID-19. The company's stores must be in 2022 January 7 to 2022
MODERNHEALTHTEC: PROFIT WARNING
Modern Health Technology (00919.HK) plans to hold a board meeting on June 28 to approve annual results
Glonghui, June 14, 丨 Modern Health Technology (00919.HK) announced that the company will hold a board meeting in Hong Kong on June 28, 2023 (Wednesday) to (including) approve the publication of the company and its subsidiaries' annual results for the fiscal year ending March 31, 2023 and consider dividends (if any).
MODERNHEALTHTEC: NOTIFICATION OF BOARD MEETING
Modern Healthcare Unit Secures Asset Management License in Hong Kong
04:13 AM EDT, 03/21/2023 (MT Newswires) -- Hong Kong's Security and Futures Commission granted a license to Modern Healthcare Technology Holdings' (HKG:0919) subsidiary, Delta Fund Management, accordi
Analysis
Price Target
No Data
